Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Rhode currently holds 77,500 shares of HCW Biologics Inc. (HCWB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Rhode has been a net buyer of HCWB stock. They have purchased $100.0K and sold $0 worth of shares.
Peter Rhode's most recent insider trade was on Dec 11, 2023, when they sold 14,000 shares at $0.14 per share.
Peter Rhode serves as Executive at HCW Biologics Inc. (HCWB). They have executed 5 insider transactions totaling $100.0K over their tenure at the company.
Peter Rhode holds the position of Executive at HCW Biologics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Peter Rhode has shown a buying trading pattern, with $100.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter Rhode was on Jul 22, 2021, when they purchased $100.0K worth of HCWB shares. This transaction involved 12,500 shares at $8.00 per share.
Peter Rhode currently owns 77,500 shares of HCW Biologics Inc. (HCWB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Rhode's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Rhode has 5 Form 4 filings on record as an insider at HCW Biologics Inc..
Set alerts for Peter Rhode and 40,000+ other insiders.